Prices may be delayed up to 20 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics Previous close 13,352.00
Open 0.00
Day range —
52-week range 10,270.00 14,288.78
Off day high 0.00%
Off 52-week high −6.56%
Volume 2.00
Avg. volume (3M) 18.00
Market cap 1.37T
EPS (TTM) 727.70
Forward P/E —
P/E ratio (TTM) 18.35
Dividend yield 0.48% (64.06)
Beta (5Y) —
Shares outstanding 101.14M
Short interest —
Earnings date Oct 30, 2026
Analyst target —
Profit margin —
No recent coverage in the 4Search index.
From articles in the 4Search news index.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.
From Wikipedia , CC BY-SA 4.0
Earnings
Next report: Fri, Oct 30, 2026
Not eligible for Gainers, Losers, Most active (U.S. stocks worth $2 billion or more only).
Not eligible for Small-cap gainers, Aggressive small caps (U.S. stocks worth under $2 billion only).
Not eligible for Growth tech (U.S. technology stocks only).
Not eligible for Undervalued large caps (U.S. stocks worth $10 billion or more only).
A day counts when it ranked in the top 25 of a list. Tracked since Oct 10, 2026.
Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4Search index. Terms of use .